FIELD: biotechnology.
SUBSTANCE: invention discloses a new culture medium containing an MST1/2 kinase inhibitor. Invention can be used for cultivation or propagation in vitro of epithelial cells of primary laryngeal cancer. Cell model obtained using the culture medium for primary cells according to the present invention, can be used to assess efficacy and screening of drugs suitable for treating laryngeal cancer.
EFFECT: shorter period of cell cultivation in comparison with known analogues.
11 cl, 10 dwg, 6 tbl, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| CULTURE MEDIUM FOR EPITHELIAL CELLS OF ESOPHAGEAL SQUAMOUS CELL CARCINOMA, METHOD OF CULTIVATION AND USE THEREOF | 2020 |
|
RU2816529C1 |
| CULTURE MEDIUM FOR PRIMARY CELLS OF OESOPHAGEAL SQUAMOUS CELL CARCINOMA AND METHOD OF CULTURING SAID CELLS | 2020 |
|
RU2822035C1 |
| CULTURE MEDIUM FOR PRIMARY EPITHELIAL CELLS OF MAMMARY GLAND, METHOD OF CULTIVATION AND USE THEREOF | 2019 |
|
RU2819362C1 |
| CULTURE MEDIUM FOR STEM CELLS | 2012 |
|
RU2714256C2 |
| CULTURE MEDIUM FOR PRIMARY CELLS OF STROMAL TUMOR OF GASTROINTESTINAL TRACT, METHOD FOR CULTIVATION THEREOF AND USE THEREOF | 2021 |
|
RU2826875C1 |
| CULTURE MEDIUM FOR EPITHELIAL STEM CELLS AND ORGANOIDS, CONTAINING THEREOF | 2010 |
|
RU2555545C2 |
| LIVER ORGANOID, VERSIONS OF USE THEREOF AND CULTURE METHOD FOR PRODUCTION THEREOF | 2011 |
|
RU2579995C2 |
| METHOD OF PRODUCING, CULTURING AND CHARACTERIZING BRONCHIAL AND PULMONARY ORGANELLES FROM HUMAN INDUCED PLURIPOTENT STEM CELLS | 2022 |
|
RU2821564C2 |
| METHOD OF FORMING TRABECULAR BONE ORGANOID | 2023 |
|
RU2818357C1 |
| IMPROVED DIFFERENTIATION METHOD | 2017 |
|
RU2772435C2 |
